Denali Therapeutics Inc. (DNLI) › Net IncomeDenali Therapeutics Inc. (DNLI) — Net IncomeAnnual figures by period end, from SEC filings.2016-12-31: -$86.65M2017-12-31: -$88.19M2018-12-31: -$36.24M2019-12-31: -$197.61M2020-12-31: $71.14M2021-12-31: -$290.58M2022-12-31: -$325.99M2023-12-31: -$145.22M2024-12-31: -$422.77M2025-12-31: -$512.54M-$512.54M2016-12-31Net Income (USD)2025-12-31Period endedNet IncomeChange YoYSource filing2025-12-31-$512.54M—2026-02-26From 2025-01-012024-12-31-$422.77M—2026-02-26From 2024-01-012023-12-31-$145.22M—2026-02-26From 2023-01-012022-12-31-$325.99M—2025-02-27From 2022-01-012021-12-31-$290.58M-508.5%2024-02-28From 2021-01-012020-12-31$71.14M—2023-02-27From 2020-01-012019-12-31-$197.61M—2022-02-28From 2019-01-012018-12-31-$36.24M—2021-02-26From 2018-01-012017-12-31-$88.19M—2020-02-27From 2017-01-012016-12-31-$86.65M—2019-03-12From 2016-01-01Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)